PFE

Top 10 Dow Dividend Stocks for May

In a low-yield environment, attractive blue-chips look even more appealing. Here are the top 10 Dow Dividend stocks for May. More 

Nexium OTC: Popular Pill Now Available Without Prescription

A nonprescription version of the popular heartburn drug Nexium was jut released by Pfizer and it's significantly cheaper than Nexium. More 

5 Stocks to Sell in June

The market is making record highs, but these names sure aren't. Weak technicals suggest plenty more downside to come, which makes them stocks to sell. More 

Is AstraZeneca a Buy After Pfizer Breakup? 3 Pros, 3 Cons

AZN turned down Pfizer's offer -- a premium of more than 40% for AZN stock -- sending shares down more than 10%. But is that actually a buying opportunity? More 

AZN, PFE: AstraZeneca Rejects ‘Final’ Pfizer Bid

AstraZeneca (AZN) has rejected another bid from Pfizer (PFE) -- a reported $119 billion improved takeover offer. More 

PFE – Here’s Why Pfizer Trading Stopped Friday

A big announcement halted trading in Pfizer Inc. (NYSE:PFE) on Friday, but it wasn't the one that many financial minds expected to hear. More 

Biggest Movers in Healthcare Stocks Now – IMGN PBYI AUXL SRPT

Healthcare stocks rose broadly on Wall Street on Friday, with the sector seeing an overall increase of 0.6%. NASDAQ:IMGN, NYSE:PBYI, NASDAQ:AUXL, NASDAQ:SRPT, NASDAQ:ARNA, NYSE:OPK, NYSE:MSA, NASDAQ:CNMD, NYSE:MCK, NYSE:OMI, NYSE:EXAM, NYSE:TEVA, NYSE:AGN, NYSE:SNY, NASDAQ:MWIV, NASDAQ:FURX, NYSE:SNN, NASDAQ:NEOG, NASDAQ:REGN, NYSE:PFE More